e-Therapeutics plc (LON:ETX) insider Trevor Mervyn Jones acquired 59,400 shares of the business’s stock in a transaction that occurred on Friday, May 12th. The shares were purchased at an average price of GBX 8 ($0.10) per share, with a total value of £4,752 ($6,011.39).

Shares of e-Therapeutics plc (ETX) traded up 7.229% during mid-day trading on Thursday, hitting GBX 11.125. The company had a trading volume of 1,473,328 shares. The company’s market capitalization is GBX 29.86 million. e-Therapeutics plc has a one year low of GBX 6.00 and a one year high of GBX 14.00. The firm’s 50-day moving average price is GBX 8.33 and its 200 day moving average price is GBX 8.34.

WARNING: This piece was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/06/15/trevor-mervyn-jones-acquires-59400-shares-of-e-therapeutics-plc-etx-stock-updated-updated-updated.html.

About e-Therapeutics plc

e-Therapeutics plc is a United Kingdom-based drug discovery and development company. The Company’s discovery platform is based on the network of pharmacology and chemical biology. The Company operates in the business segment of drug discovery and development. The Company applies its platform to the discovery of new drug candidates.

Receive News & Stock Ratings for e-Therapeutics plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for e-Therapeutics plc and related stocks with our FREE daily email newsletter.